VCM
KRYS icon

Versant Capital Management’s Krystal Biotech KRYS Stock Holding History

Versant Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.5K Buy
214
+140
+189% +$41.8K 0.01% 1057
2026
Q1 		$19.1K Buy
74
+3
+4% +$798 ﹤0.01% 1845
2025
Q4 		$17.5K Hold
71
– – ﹤0.01% 1721
2025
Q3 		$12.5K Buy
71
+2
+3% +$299 ﹤0.01% 1837
2025
Q2 		$9.48K Buy
69
+32
+86% +$4.7K ﹤0.01% 1912
2025
Q1 		$6.67K Sell
37
-16
-30% -$2.69K ﹤0.01% 1914
2024
Q4 		$8.3K Sell
53
-22
-29% -$3.9K ﹤0.01% 1511
2024
Q3 		$13.7K Buy
75
+29
+63% +$5.59K ﹤0.01% 950
2024
Q2 		$8.45K Buy
46
+38
+475% +$6.38K ﹤0.01% 1043
2024
Q1 		$1.42K Hold
8
– – ﹤0.01% 1453
2023
Q4 		$992 Hold
8
– – ﹤0.01% 1513
2023
Q3 		$928 Hold
8
– – ﹤0.01% 1548
2023
Q2 		$939 Buy
+8
New +$817 ﹤0.01% 1622

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Versant Capital Management's KRYS Position: Q2 2026 in Review

Versant Capital Management increased its Krystal Biotech (KRYS) stake by 189% in Q2 2026, buying an estimated $41.8K and bringing the position to 214 shares worth $79.5K. The position accounts for 0.01% of the portfolio, ranked #1057.

Versant Capital Management first reported a position in KRYS in Q2 2023 and has held it in 13 quarters since. 65 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Versant Capital Management held 214 shares of Krystal Biotech worth $79.5K as of Q2 2026.
  • Versant Capital Management bought 140 Krystal Biotech shares in Q2 2026, an estimated $41.8K.
  • Krystal Biotech made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1057 holding.
  • Versant Capital Management first reported a position in Krystal Biotech in Q2 2023 and has held it in 13 quarters since.
  • 65 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.